Agilon Health, Inc. (NYSE:AGL – Get Free Report) has earned a consensus recommendation of “Hold” from the fifteen research firms that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $58.7273.
Several brokerages have commented on AGL. JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective on the stock. in a report on Monday, May 4th. Weiss Ratings lowered Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $33.00 to $49.00 in a research note on Thursday, May 7th. Benchmark reissued a “buy” rating and issued a $95.00 price target (up from $13.00) on shares of Agilon Health in a report on Thursday, May 21st. Finally, Citigroup restated a “neutral” rating and set a $80.00 price objective (up from $18.75) on shares of Agilon Health in a research report on Friday, May 15th.
Check Out Our Latest Research Report on Agilon Health
Agilon Health Trading Down 0.7%
Agilon Health (NYSE:AGL – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. As a group, equities analysts forecast that Agilon Health will post -3.5 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of AGL. North Peak Capital Management LLC boosted its holdings in Agilon Health by 10.8% in the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after buying an additional 3,715,460 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Agilon Health by 196.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Agilon Health by 1,346.6% during the fourth quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after acquiring an additional 9,505,837 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Agilon Health by 30.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock valued at $5,523,000 after acquiring an additional 1,893,434 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Agilon Health by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 7,177,477 shares of the company’s stock valued at $4,944,000 after acquiring an additional 35,054 shares in the last quarter.
About Agilon Health
Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.
Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.
Featured Articles
- Five stocks we like better than Agilon Health
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
